Biocrea Overview

  • Founded
  • 2004
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Biocrea General Information


Developer of CNS drugs. The company develops drugs for various diseases such as depression, huntingon's disease, epilepsy, autism and amyotrophic lateral sclerosis diseases in Germany.

Contact Information

Formerly Known As
Biotie Therapies (Germany)
Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Primary Office
  • Meissner Strasse 191
  • 01445 Radebeul
  • Germany
+49 0351 00000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocrea Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biocrea‘s full profile, request access.

Request a free trial

Biocrea Executive Team (3)

Name Title Board Seat Contact Info
Thomas Kronbach Chief Executive Officer & Founder
Christiane Kronbach Chief Operating Officer
You’re viewing 2 of 3 executive team members. Get the full list »